telavancin has been researched along with Mediastinitis* in 1 studies
1 other study(ies) available for telavancin and Mediastinitis
Article | Year |
---|---|
Heart transplantation in a patient with heteroresistant vancomycin-intermediate Staphylococcus aureus ventricular assist device mediastinitis and bacteremia.
Vancomycin-intermediate Staphylococcus aureus (VISA) infections are an emerging problem and antibiotic options are limited. We report the first case, to our knowledge, of heteroresistant VISA mediastinitis and bacteremia in a patient with a ventricular assist device who underwent orthotopic heart transplantation with clinical cure. Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Debridement; Defibrillators, Implantable; Female; Heart Transplantation; Heart-Assist Devices; Humans; Lipoglycopeptides; Mediastinitis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2013 |